Boston Scientific

Boston Scientific is a global leader in medical technology, founded in 1979 by John Abele and Pete Nicholas. The company focuses on developing innovative medical devices for various applications, including cardiovascular, pulmonary, urology, gastroenterology, and neuromodulation. With a portfolio of over 13,000 products, Boston Scientific aims to advance less invasive and cost-effective surgical procedures, significantly impacting interventional medicine.

The company offers a wide range of devices, including those for angioplasty, cardiovascular imaging, cardiac ablation, and neuromodulation. Boston Scientific serves hospitals, clinics, and healthcare providers worldwide, helping clinicians treat over 24 million patients each year. Operating in approximately 100 countries, the company maintains 13 manufacturing centers and invests over $900 million annually in research and development to support ongoing innovation and clinical trials.

Boston Scientific emphasizes innovation, diversity, and inclusion within its corporate culture, aiming to enhance leadership roles for women and people of color while continuing to develop new medical technologies that meet patient needs.